Woman's Cancer Foundation

<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Kevin Lin, Maria I. Harrell, Amit M. Oza et al. · Cancer Discovery · 2018 · 403 citations

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

Alexi A. Wright, Kari Bohlke, Deborah K. Armstrong et al. · Gynecologic Oncology · 2016 · 359 citations · Full text

Neoadjuvant Chemotherapy, Advanced Ovarian Cancer, Medicine +8

Clear Cell Carcinoma of the Ovary: A Distinct Histologic Type with Poor Prognosis and Resistance to Platinum-Based Chemotherapy in Stage III Disease

Barbara A. Goff, Ricardo Sáinz de la Cuesta, Howard G. Muntz et al. · Gynecologic Oncology · 1996 · 355 citations

Tumoral Pathology, Endocrine-related Cancer, Medicine +10

Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study

Barbara M. Norquist, Mark F. Brady, Maria I. Harrell et al. · Clinical Cancer Research · 2017 · 230 citations · Full text

Uterine Papillary Serous Carcinoma: Evaluation of Long-Term Survival in Surgically Staged Patients

Jeffrey E. Grice, Marit Ek, Benjamin E. Greer et al. · Gynecologic Oncology · 1998 · 150 citations

Surgical Oncology, Tumoral Pathology, Gynecological Surgery +6